Cambridge, MA, United States of America

Irina Leaf


 

Average Co-Inventor Count = 11.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Stoneham, MA (US) (2020)
  • Cambridge, MA (US) (2019 - 2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: **Inventor Spotlight: Irina Leaf**

Introduction

Irina Leaf is a distinguished inventor based in Cambridge, MA. With a focus on pharmaceutical innovations, she has made significant contributions to the field of medicinal chemistry, particularly in the development of IRAK4 inhibiting agents.

Latest Patents

Irina holds three patents, with her latest innovations being targeted compounds described as IRAK4 inhibitors. These compounds, represented by Formula I, include pharmaceutically acceptable salts and detail methods for their use and production. The applications for these compounds are extensive, as they are useful in treating a variety of conditions, including inflammatory diseases, autoimmune diseases, cancer, cardiovascular diseases, central nervous system disorders, skin diseases, ophthalmic conditions, and bone diseases.

Career Highlights

Currently, Irina is employed at Biogen MA Inc., where she continues to explore cutting-edge solutions to complex health issues. Her work has garnered recognition for its potential impact on various therapeutic areas, affirming her status as a leading figure in her domain.

Collaborations

Throughout her career, Irina has collaborated with notable colleagues such as Timothy Raymond Chan and Kevin Guckian. These partnerships have fostered an environment of innovation and creative problem-solving, further enhancing the development of her patented compounds.

Conclusion

Irina Leaf's contributions to the field of pharmacology illustrate her commitment to addressing significant health challenges through innovation. As her work progresses, her patents shine a light on the potential advancements that IRAK4 inhibiting agents may bring to medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…